Published in
Elsevier, The Lancet Oncology, 9(17), p. 1283-1294, 2016
DOI: 10.1016/s1470-2045(16)30167-x
Links
Tools
Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial
Journal article published in 2016 by
Anas Younes,
Armando Santoro 
,
Margaret Shipp,
Pier Luigi Zinzani,
John M. Timmerman,
Stephen Ansell,
Philippe Armand,
Michelle Fanale,
Voravit Ratanatharathorn,
John Kuruvilla,
Jonathon B. Cohen,
Graham Collins,
Kerry J. Savage,
Marek Trneny ,
Kazunobu Kato
and other authors.
,
Margaret Shipp,
Pier Luigi Zinzani,
John M. Timmerman,
Stephen Ansell,
Philippe Armand,
Michelle Fanale,
Voravit Ratanatharathorn,
John Kuruvilla,
Jonathon B. Cohen,
Graham Collins,
Kerry J. Savage,
Marek Trneny ,
Kazunobu Kato
and other authors.
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 